XML 41 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2026
Summary of Significant Accounting Policies [Abstract]  
Schedule of Inventory Inventory that is in excess of current and projected use is reduced by an allowance to a level that approximates its estimate of future demand. Products that are determined to be obsolete are written down to net realizable value.
(dollars in thousands)  March 31,
2026		   December 31,
2025		 
Raw material  $23,033   $14,153 
Work in process   6,774    1,470 
Finished goods   5,470    7,992 
Less inventory reserves   (991)   (1,652)
Total inventory, net  $34,286   $21,963 
Schedule of Reconciliation of Basic to Diluted Shares

The reconciliation of basic to diluted shares is as follows (in thousands except share data):

 

   Three Months Ended
March 31,		 
   2026   2025 
Calculation of basic income (loss) per share attributable to stockholders        
Net income (loss) attributable to stockholders  $361,659   $(15,343)
Net income attributable to participating securities   (103,924)   
-
 
Net income (loss) attributable to common stockholders - basic  $257,735   $(15,343)
Weighted-average common shares outstanding – basic   445,088,835    105,004,818 
Earnings per share - basic  $0.58   $(0.15)
Calculation of diluted income (loss) per share attributable to stockholders          
Net income (loss) attributable to stockholders  $361,959   $(15,343)
Net income attributable to participating securities   (103,924)   
-
 
Net income (loss) attributable to common stockholders - diluted  $257,735   $(15,343)
           
Weighted-average common shares outstanding – basic   445,088,835    105,004,818 
Common stock warrants   278,260    
-
 
Common stock options   10,012,986    
-
 
Restricted stock units   6,308,924    
-
 
Other   16,951    
-
 
Weighted-average common shares outstanding – diluted   461,705,956    105,004,818 
Net income (loss) per share - diluted  $0.56   $(0.15)
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share

The following potentially dilutive securities for the three months ended March 31, 2026 and 2025, have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.

 

   Three Months Ended
March 31,		 
   2026   2025 
Warrants to purchase common stock   195,527,101    25,384,610 
Options to purchase common stock   654,350    9,349,311 
Contingently issuable shares   109,456,221    
-
 
Potential shares issuable under 2022 Convertible Promissory Notes   
-
    19,502,416 
Potential shares issuable under 2023 Additional Notes   
-
    30,237,267 
Potential shares issuable under 2024 Additional Notes   
-
    42,348,142 
Restricted stock units   
-
    1,458,600 
Total potentially dilutive securities   305,637,672    128,280,346